Skip to content. | Skip to navigation

Personal tools

  • Le CIRI sur Linkedin
Sections

Managing bodies

logo Inserm      logo cnrslogo ENSL       logo ucb1


Secondary managing bodies

logo ENSL logo ucb1

You are here: Home
 
Publications
Alexandre Legrand, Rémi Demeure, Amandine Chantharath, Carine Rey, Julie Baltenneck, Cameron L. M. Gilchrist, Joana L. Rocha, Clara Loyer, Léa Picard, Andrea Cimarelli, Martin Steinegger, Francois Rousset, Peter H. Sudmant and Lucie Etienne
Urban environment and RSV: a retrospective observational study of neighbourhood factors associated with the risk of severe disease in the infant population of a metropolitan area, Lyon, France Publications of RSV Study Group Lyon
Natural killer (NK) cells have antitumor activity that is primed by IL-15 and IL-18, components of a cytokine cocktail used in NK cell–based cancer immunotherapy. Fallone et al. found that IL-15 and IL-18 synergized to activate the complex mTORC1, which resulted in increased proliferation and function of both mouse and human NK cells. IL-15 and IL-18 stimulated mTORC1 activity through distinct pathways not previously implicated in its regulation. The combination of IL-15 and IL-18 improved the survival of mice engrafted with tumor cells, suggesting a therapeutic strategy to enhance the efficacy of NK cell–based cancer immunotherapy
Lung virome convergence precedes hospital-acquired pneumonia in intubated critically ill patients Anani et al. Cell Rep Medicine - Team VirPath-CARVI
 
News
Félicitations à Lucie ETIENNE, Directrice de Recherche au Centre International de Recherche en Infectiologie (CNRS/ ENS de Lyon / INSERM / Université Claude Bernard Lyon 1 / Hospices Civils de Lyon / Université Jean Monnet – Saint-Etienne) pour l’obtention d’un ERC Consolidator Grant pour le projet FUNEVO !
Publication of the I2BA team in The Journal of Experimental Medicine
International Call for the Recruitment of an Early-Career Team Leader in Virology at CIRI.
Two recent papers, resulting from international collaborations between Bénédicte PY, DR INSERM, NLRP3 Team, and BioAge Labs in the US, R. Coll in Ireland, M. Geyer in Germany, and R. Karki in Korea, are featured in a joint highlight in Nature Reviews Drug Discovery: www.nature.com/articles/d41
Job offers
The HEAL team is seeking for a PhD candidate to start a research project on the cellular and molecular aspects of “Orthonairovirus: molecular determinants of transmission”
The VIRPATH laboratory at the International Center for Research in Infectiology (CIRI) is inviting applications from motivated, independent postdoctoral researchers to lead cutting-edge projects foc (...)
L’équipe dirigée par Olivier Thaunat recrute un·e ingénieur·e en Immunologie dans le cadre d’un projet ANR portant sur les mécanismes d’allo-reconnaissance en transplantation
Post-doc offer at the CERP (Center of Excellence in Respiratory Pathogens)
PERSIST Lab - Nicolas Personnic
A PhD under a "CIFRE convention" is opened in EIA team. It will start in September 2024.
Agenda

Conferences

“Host adaptations to viral infections” Meeting at CNRS Station Biologique de Roscoff: Register now!

Peter Sudmant (UC Berkeley, USA), David Enard (Univ. Arizona, USA) and Lucie Etienne (CIRI, CNRS / (...)

Réunion annuelle AC42

Réseau National Hépatites de l'ANRS | Maladies Infectieuses Emergentes

CFATG10

10èmes Journées Scientifiques de l’Autophagie

Seminars

séminaire CIRI : Pr. Miles W CARROLL (17.12.2025)

“ EBOV : Outbreaks, molecular epidemiology, immunity, persistence and surveillance ”

SIDACTION - Rencontre scientifique & solidaire

Pour renforcer la transversalité entre ses différents programmes et axes d’intervention et (...)

Thesis defenses

Soutenance de thèse de Pauline Bronnec, équipe I2BA (19.12.2025 à 14h00)

"Identification des variants pathogènes du gène MEFV"

Soutenance de thèse de Julie Plantade, équipe Horigene (17.12.2025 à 14h00)

" Antibiorésistance chez la bactérie pathogène opportuniste Acinetobacter baumannii : apports (...)